UK Authorizes Recombinant Flu Vaccine For 2020
The influenza vaccine Flublok has been given authorization for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency (MHRA) for immunization against flu in this year’s seasonal flu program to meet public health need. The MHRA assessment was based in part on evidence from another closely related Sanofi flu vaccine, Supemtek.
This was recommended for approval by the European Medicines Agency in September 2020.
Flublok is made by Sanofi and is licensed for use in the USA by the Food and Drug Administration (FDA). It has been used there since 2016 and has been distributed to over 9 million people. The FDA considers the vaccine safe and acceptable for use.